Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. - Wikidata - awgldk - TriplyDB

Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures.

Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures.

http://www.wikidata.org/entity/Q35505244

about

Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research The fracture mechanics of human bone: influence of disease and treatment Pathogenesis, management and prevention of atypical femoral fractures Bone composition: relationship to bone fragility and antiosteoporotic drug effects Skeletal complications of bisphosphonate use: what the radiologist should know Periprosthetic bone loss: diagnostic and therapeutic approaches Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures.Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistry The fragile elderly hip: mechanisms associated with age-related loss of strength and toughness Identifying Novel Clinical Surrogates to Assess Human Bone Fracture Toughness.Theoretical consideration of the effect of drug holidays on BMD and tissue age.The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate Insights into reference point indentation involving human cortical bone: sensitivity to tissue anisotropy and mechanical behavior.Studying variations in bone composition at nano-scale resolution: a preliminary report.Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.Multiscale contribution of bone tissue material property heterogeneity to trabecular bone mechanical behavior.The Effect of Osteoporosis Treatments on Fatigue Properties of Cortical Bone Tissue.Millimeter-scale mapping of cortical bone reveals organ-scale heterogeneity.Bone microdamage, remodeling and bone fragility: how much damage is too much damage?Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women.Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?Atypical femoral fractures: epidemiology, etiology, and patient management Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls.Research perspectives: The 2013 AAOS/ORS research symposium on Bone Quality and Fracture Prevention.Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions Evidence of altered matrix composition in iliac crest biopsies from patients with idiopathic juvenile osteoporosis Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality.Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI.Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite.Examining the Relationships Between Bone Tissue Composition, Compositional Heterogeneity, and Fragility Fracture: A Matched Case-Controlled FTIRI Study.Atypical femoral fractures Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model Compressive loading of the murine tibia reveals site-specific micro-scale differences in adaptation and maturation rates of bone."Atypical" atypical femur fractures and use of bisphosphonates.Presence of pyrophosphate in bone from an atypical femoral fracture site: A case report.Bisphosphonates and atypical subtrochanteric fractures of the femur.Bone mineralization: from tissue to crystal in normal and pathological contexts.

P2860

Q26782834-243110F9-68EE-49C8-85B7-9DA11A07D518 Q26784190-5E0A5B74-13AC-4F63-85E2-C950426BDB66 Q26824555-8B5B7DFE-3B08-4878-A3C8-4928B32214F4 Q26863596-78228DE2-66FA-4BD9-9B94-69EF593E7720 Q27010157-E2B7A9AB-4BF7-4698-BC01-A724CC3B6BDF Q27024847-A6A344A4-A6E8-4388-A1D3-14CD46C37AA5 Q27025945-6B300F42-483C-4445-ACF0-8D5C52BE0FD7 Q27027254-41E6C089-A48C-45CB-926F-F3364A72E9E0 Q28393488-48D69B97-0C46-447E-B50B-137EB05568AA Q30439769-B79F63DD-E46D-457A-A9AD-68BA0C38D96E Q30886905-62411F1B-B1E5-48E7-87C7-D4D744101388 Q33667379-BC385CAD-0DD7-4A68-89AD-13DB2595EEED Q33700394-E9765EAC-7768-4149-84D8-6DB86BD091F3 Q33958167-CB4F77F3-63C5-4757-9C1B-6FA9B3499337 Q34315823-B5BE4642-B156-46C7-ABF4-7B78BDA796AF Q34468292-F07BBC38-7BA8-4038-8D14-57AAEFB48663 Q34975039-1F2C5132-FD9C-40A1-8328-3E8003140606 Q35012189-6A49ED08-D225-40BB-9B67-7EDEA5CBC2A9 Q35138212-5783B393-942F-4187-BCE1-1480376B1A7F Q35211086-5A87F3B9-D935-49B8-BD43-7392D6C87C40 Q35595181-53368BF9-ECE6-4B66-A27D-E3AB2E93D8C3 Q35731108-D3AC8CF7-28EA-4E25-87FF-783D4F1AFB64 Q35780856-F5CC6BF6-BCDA-4801-AEA3-79D98018B0BF Q35807492-A75F39B9-76DC-45AC-8ED1-A92C1CD19A39 Q36016579-6582E8E9-8D9E-4FC5-8019-4E605AD441AE Q36449001-2D20DF1F-4940-4E55-8CE5-B6A9CB8894C2 Q36473294-9397D4B4-834B-49CB-9041-F934A6E1EE6E Q36583064-A0A711AD-BA60-4889-A225-783C1DCE6374 Q36593896-4D124077-8924-4147-B451-31BD0CF65DF2 Q36633388-68164DB9-003C-4FEA-97E7-BA915D37AA71 Q36642684-1D1C5D6F-2372-4652-BD99-7DECFA647A83 Q36780810-60693178-2B8B-462B-9EF3-AF4D52CC5032 Q36889362-34FEC068-75CB-4BF6-8B47-F044E1396025 Q37008039-C719F2E2-563B-4583-9F5C-D8D9529D21CB Q37244297-5361E9B1-E329-4198-BE48-6878C4D3479F Q37639355-C372CB5C-2756-47A9-9658-3397B45172AA Q37653262-B85C5AA6-15A9-4FD7-8FB8-9601154F686E Q37720674-D482CBF7-E9FC-4E2D-947A-D2C4357F4D45 Q37733851-AE75067E-F9DD-423A-A5F0-ED10BA5E166D Q38066387-D69D9749-A334-4F11-BDE5-B3DC30B5FAF4

P2860

Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures.

http://www.wikidata.org/entity/Q35505244

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Reduced cortical bone composit ...... and subtrochanteric fractures.

@ast

Reduced cortical bone composit ...... and subtrochanteric fractures.

@en

type

label

Reduced cortical bone composit ...... and subtrochanteric fractures.

@ast

Reduced cortical bone composit ...... and subtrochanteric fractures.

@en

prefLabel

Reduced cortical bone composit ...... and subtrochanteric fractures.

@ast

Reduced cortical bone composit ...... and subtrochanteric fractures.

@en

P1433

Q35505244-B1FF653D-3586-4F31-BAA3-6E26341AE134

P1476

Q35505244-A11B41D3-62B3-47A4-82E9-E1B3377B9945

P2093

Q35505244-1F148F69-8296-40FD-BF5B-C2F397D3C22C

Q35505244-3ECDFEF7-DF98-4482-AC3F-68584C456C74

Q35505244-565D69D9-8621-4539-9FE8-E00CF8D9233C

Q35505244-8FCFC6D9-9F5F-4AC7-87B0-94A475C86BFE

Q35505244-980131D6-D4D0-4E03-9D87-698B8BB840C3

Q35505244-9F685A0D-0976-484C-B071-6A075A72280B

Q35505244-BDAAE6F1-6C2B-4F0F-B799-507AD889DF2C

P2860

Q35505244-03EB5D40-7188-4316-BCF4-498530A5791D

Q35505244-06A9B940-937F-43BF-A7A6-CE08D6026012

Q35505244-080C6691-282E-437B-B60C-87894B3027CD

Q35505244-0CA6842B-7AC0-4131-9AC1-974AF204BA1B

Q35505244-0D13A9A4-5D4E-4664-B92B-BCD1FD256811

Q35505244-1A05B9B8-BBD4-480D-A7E2-357CE4553310

Q35505244-22C3975C-2C0E-4A1C-971C-EFA1EE844A4C

Q35505244-2B1E6D23-F87B-426F-A451-B1484A73CEF4

Q35505244-3B466F59-ADC3-4931-BF9B-8F110E0C310D

Q35505244-3F4D31EF-6D4E-405D-8959-4F2AA9136685

P304

Q35505244-F1C09A8A-A5C9-4CF5-AF56-052B7067794C

P31

Q35505244-62E213AD-D4A2-406B-BBE7-2B6E91708DF7

P356

Q35505244-2DB39FAD-E476-4215-94F4-9B0404C3E8F9

P433

Q35505244-61B10205-9C33-4C37-BD9A-FD8CE5670CF5

P478

Q35505244-E11C2D92-F160-4F31-9ED9-236C4B4F30E4

P50

Q35505244-E14C35CA-A4D2-44C9-AFCD-D6CDA0A82E75

Q35505244-E6479286-3982-4EB4-9A7F-74C20FBF682E

P577

Q35505244-F9DA18BA-1F3A-4074-9825-3A12A0C0482A

P5875

Q35505244-828B9E2E-53C7-4604-A7E2-6756E8353C6C

P698

Q35505244-B1CB5580-8AD3-41CA-8454-1029E04D7B55

P932

Q35505244-E7D721F8-7E33-47D7-A6BB-98321FB37BA3

P356

P1433

Journal of Bone and Mineral Research

P1476

Reduced cortical bone composit ...... and subtrochanteric fractures

@en

P2093

Andre D Shaffer

http://www.w3.org/2001/XMLSchema#string

Brian J Rebolledo

http://www.w3.org/2001/XMLSchema#string

Brian P Gladnick

http://www.w3.org/2001/XMLSchema#string

Dean G Lorich

http://www.w3.org/2001/XMLSchema#string

Dennis S Meredith

http://www.w3.org/2001/XMLSchema#string

Joseph M Lane

http://www.w3.org/2001/XMLSchema#string

Joseph T Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals

Nanoscale heterogeneity promotes energy dissipation in bone.

Effects of non-enzymatic glycation on cancellous bone fragility.

Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crest.

Infrared analysis of bone in health and disease.

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

P304

672-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.560

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Adele L. Boskey

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51785867

http://www.w3.org/2001/XMLSchema#string

P698

22072397

http://www.w3.org/2001/XMLSchema#string

P932

4404705

http://www.w3.org/2001/XMLSchema#string